Fundraise

DNA X raises $8.1M from insider-linked investor after asset sale reset

What's the deal? DNA X, the company formerly known as Sonim TechnologiesDealroom has a profile for this one. Try Dealroom → (NASDAQ: SONM), agreed on June 29, 2026, to sell 1,346,531 shares of Series B Convertible Preferred Stock at $6.00 each to DNA Holdings Venture, raising $8.1 million. The deal combines $5 million in cash with the cancellation of $3.1 million owed under a convertible promissory note issued to DNA Holdings in May 2026.

Who's behind it? DNA Holdings holds more than 5% of the company's stock and is tied to board member Scott Walker, making this a related-party financing. The preferred shares are non-voting and convert to common stock once shareholders approve.

Why now? DNA X recently sold its core assets to Pace Car Acquisition/NEXA and rebranded from Sonim Technologies, leaving it a micro-cap with a market value of roughly $8.7 million. The $8.1 million round nearly matches its public equity value, materially recapitalising the business as it resets.

What's the money for? The company said it intends to use net proceeds for working capital and general corporate purposes. DNA Holdings also secured the right to participate in future equity and debt financings for 12 months, capped at 50% of principal sold.

What could go wrong? Because the capital comes from an insider-linked investor rather than the open market, the deal may raise governance and valuation questions for outside shareholders. A planned consulting agreement with DNA Holdings, Walker, and Brock PierceDealroom has a profile for this one. Try Dealroom → would hand the consultants 2,494,000 common shares, subject to separate shareholder approval.

The signal: DNA X's re-raise fits a wider pattern in the small-cap market, where many companies lean on structured or insider-linked financings rather than traditional growth equity. For a business just out of an asset sale, the round signals insider conviction in the post-restructuring strategy — even if it stops short of broad market validation.

Read more: StreetInsider

Image credit: Generated with Gemini

More top stories